Ritter Pharmaceuticals, Inc.
(NASDAQ : RTTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-0.17%17.232.0%$167.17m
PRGOPerrigo Co. Plc
2.30%45.906.8%$129.01m
SAGESAGE Therapeutics, Inc.
2.44%139.799.5%$123.27m
JAZZJazz Pharmaceuticals Plc
1.32%129.072.2%$95.40m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.07%137.296.3%$80.20m
PTLAPortola Pharmaceuticals, Inc.
3.59%26.537.7%$62.92m
ICPTIntercept Pharmaceuticals, Inc.
-0.19%113.4518.6%$56.49m
MNKMallinckrodt Plc
3.72%20.6421.1%$45.66m
CTLTCatalent Inc
1.12%35.612.4%$42.08m
AXSMAxsome Therapeutics, Inc.
-1.92%8.162.7%$41.76m
UTHRUnited Therapeutics Corporation
1.37%115.7514.4%$40.50m
ICLRICON Plc
-0.18%133.184.1%$40.47m
ENDPEndo International Plc
-1.52%9.708.9%$38.65m
HZNPHorizon Pharma plc
-1.71%21.847.4%$28.32m
MDCOMedicines Company
0.25%20.0021.8%$27.91m

Company Profile

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.